003060 — Aprogen Biologics Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩46bn
- KR₩292bn
- KR₩73bn
Annual cashflow statement for Aprogen Biologics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9,151 | 5,584 | -115,330 | -104,980 | -168,297 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -10,299 | -8,265 | 66,047 | 55,974 | 116,995 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6,952 | 26,205 | -5,508 | -1,009 | -6,016 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6,227 | 25,728 | -33,651 | -30,996 | -38,233 |
| Capital Expenditures | -1,442 | -1,545 | -28,396 | -15,452 | -9,780 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -21,714 | -51,456 | -66,810 | -36,271 | -75,340 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -23,156 | -53,001 | -95,206 | -51,722 | -85,119 |
| Financing Cash Flow Items | -0.955 | -455 | 2,943 | -2,468 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -350 | 15,782 | 115,289 | 84,972 | 135,137 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -29,722 | -11,465 | -13,555 | 2,253 | 12,086 |